SHILPAMED.NSSHILPAMED.NSNSE
Loading
EPS Diluted Over TimeStable
Percentile Rank43
3Y CAGR+3.5%
5Y CAGR-15.9%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
+3.5%/yr
vs -13.7%/yr prior
5Y CAGR
-15.9%/yr
Recent acceleration
Acceleration
+17.1pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
20254.02+119.1%
20241.83+197.9%
2023-1.88-151.7%
20223.63-60.0%
20219.06-5.3%
20209.57+39.1%
20196.88+5.4%
20186.54-5.4%
20176.91+1.6%
20166.79-